Jazz Pharmaceuticals plc Financial Ratios — JAZZ Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	218.85	195.27	95.42	67.43	50.83	54.83	21.42	-33.13	-28.65	51.46	55.84	-40.16
Return on Assets (%)	64.21	26	10.29	2.09	9.88	9.76	9.83	8.66	9.74	3.95	-3.5	-1.94	3.73	4.79	-3.01
Return on Capital (%)	-32.6	- -	48.8	8.16	25.98	21.88	- -	20.81	- -	10.44	- -	- -	- -	- -	- -
Return on Invested Capital (%)	94.5	- -	14.01	7.23	14.8	13.72	- -	12.88	- -	12.42	- -	- -	- -	- -	- -
Gross Margin (%)	94.88	86.62	88.29	89.99	92.26	92.92	93.19	93.57	94.08	93.7	85.76	85.23	88.64	89.05	88.21
EBITDA Margin (%)	49.82	46.43	48.99	48.71	48.9	49.01	48.12	46.25	46.84	44.16	23.36	31.2	32.24	34.08	28.45
Operating Margin (%)	46.95	33.76	39.58	37.31	40.74	41.36	37.92	34.78	29.71	32.39	5.5	14	15.59	17.86	12.13
Incremental Operating Margin (%)	71.11	22.32	51.48	30.71	67.25	46.37	-1.19	16.12	-5.68	61.01	-81.46	60.51	48.8	54.97	-105.22
Pretax Margin (%)	45.9	30.27	35.3	12.92	32.91	35.78	27.25	28	21.02	11.64	-3.65	-10.19	7.77	11.56	-14.71
Profit Margin (%)	45.9	49.25	24.79	4.98	24.87	26.67	30.14	23.64	24.21	10.1	-10.65	-6.12	10.82	13.77	-8.35
Net Income to Common Margin (%)	45.9	49.25	24.79	4.98	24.87	26.67	30.14	23.64	24.21	10.1	-10.65	-6.12	10.82	13.77	-8.35
Effective Tax Rate (%)	- -	- -	29.76	62.18	24.41	25.4	- -	15.14	- -	12.18	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	218.85	195.27	95.42	67.43	50.83	54.83	21.42	-33.13	-28.65	51.46	55.84	-40.16

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	457	550	1,342	1,188	2,030	1,581	1,596	1,771	2,249	6,153	5,812	5,792	6,162	5,424
ST Debt	- -	30	6	9	38	36	41	33	46	261	47	47	624	46	1,045
LT Debt	- -	427	544	1,333	1,151	1,994	1,540	1,563	1,725	1,989	6,106	5,765	5,167	6,117	4,379
Total Debt/EBITDA	- -	1.68	1.29	2.35	1.83	2.78	2.03	1.83	1.75	2.16	8.51	5.09	4.68	4.44	4.47
Net Debt/EBITDA	-0.61	0.26	-0.2	1.15	0.31	2.28	1.53	1.47	0.96	0.99	7.55	4.24	3.4	2.67	3.27
Total Debt/EBIT	- -	2.31	1.59	3.07	2.2	3.3	2.58	2.43	2.76	2.94	36.13	11.35	9.69	8.48	10.48
Net Debt/EBIT	-0.64	0.35	-0.25	1.5	0.37	2.7	1.95	1.96	1.51	1.35	32.06	9.45	7.04	5.09	7.66
EBITDA to Interest Expense	84.79	16.13	15.88	10.84	11.38	11.77	10.02	11.14	14.01	10.47	2.59	3.96	4.27	5.82	6.22
EBITDA-CapEx/Interest Expense	81.17	14.8	15.27	6.3	10.75	8.81	8.55	9.46	11.49	6.66	2.43	2.23	4.12	5.62	5.15
EBIT to Interest Expense	79.89	11.73	12.83	8.3	9.48	9.94	7.89	8.38	8.89	7.68	0.61	1.78	2.06	3.05	2.65
Interest Expense	2	17	27	53	57	62	78	78	72	100	279	288	289	238	195
Common Equity/Total Assets	-137.98	-3.11	0.83	1.04	9.08	11.02	17.92	16.16	19.28	17.75	6.75	6.77	7.71	9.39	5.54
Long-Term Debt/Equity (%)	- -	38.09	42.02	97.21	71.99	106.19	56.78	56.68	55.45	54.34	153.99	186.83	138.27	149.41	101.4
Long-Term Debt/Capital (%)	- -	107.98	95.75	96.79	77.18	77.92	61.64	64.12	60.76	58.33	87.44	88.07	77.47	83.91	72.14
Long-Term Debt/Total Assets (%)	- -	21.72	24.32	39.92	34.53	41.53	30.07	30.04	31.15	30.43	49.65	53.21	45.35	50.92	37.56
Total Debt/Equity (%)	- -	40.74	42.45	97.9	74.34	108.11	58.27	57.9	56.93	61.46	155.17	188.35	154.98	150.53	125.59
Total Debt/Capital (%)	- -	115.48	96.73	97.47	79.7	79.33	63.27	65.49	62.39	65.98	88.11	88.79	86.83	84.53	89.35
Total Debt/Total Assets (%)	- -	23.23	24.57	40.21	35.66	42.28	30.86	30.68	31.98	34.41	50.03	53.64	50.83	51.3	46.52
Net Debt to Equity	-42.57	6.2	-6.68	48.02	12.49	88.62	44.05	46.67	31.18	28.34	137.66	156.94	112.57	90.28	91.84
Net Debt/Capital (%)	19	835.11	127.37	94.98	39.74	75.88	56.55	60.47	44.05	44.1	85.4	85.5	81.46	75.78	84.78
EBITDA	136	272	427	571	648	729	779	874	1,013	1,044	723	1,142	1,236	1,387	1,214
EBITDA-CapEx	130	250	411	332	612	546	665	743	830	664	677	644	1,193	1,339	1,004
Operating Income (Loss)	128	198	345	438	540	615	614	658	642	765	170	512	598	727	518

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	2.99	2.02	3.12	3.16	4.36	1.65	2.04	2.39	2.96	3.26	0.73	0.94	1.06	2.88	1.09
Current Ratio	3.77	2.88	4.24	4.69	5.55	2.91	3.29	3.57	4.47	4.34	3.23	2.79	2.24	4.46	1.86
Quick Ratio	3.64	2.42	3.73	4.01	5.29	2.56	2.81	3.15	3.93	3.87	1.43	1.64	1.52	3.57	1.46
CFO/Avg Current Liab	2.69	2.04	1.46	1.94	2.4	2.45	2.51	2.5	2.19	1.77	1.06	1.46	0.88	1.08	0.83
Common Equity/Total Assets	-137.98	-3.11	0.83	1.04	9.08	11.02	17.92	16.16	19.28	17.75	6.75	6.77	7.71	9.39	5.54
Long-Term Debt/Equity (%)	- -	38.09	42.02	97.21	71.99	106.19	56.78	56.68	55.45	54.34	153.99	186.83	138.27	149.41	101.4
Long-Term Debt/Capital (%)	- -	107.98	95.75	96.79	77.18	77.92	61.64	64.12	60.76	58.33	87.44	88.07	77.47	83.91	72.14
Long-Term Debt/Total Assets (%)	- -	21.72	24.32	39.92	34.53	41.53	30.07	30.04	31.15	30.43	49.65	53.21	45.35	50.92	37.56
Total Debt/Equity (%)	- -	40.74	42.45	97.9	74.34	108.11	58.27	57.9	56.93	61.46	155.17	188.35	154.98	150.53	125.59
Total Debt/Capital (%)	- -	115.48	96.73	97.47	79.7	79.33	63.27	65.49	62.39	65.98	88.11	88.79	86.83	84.53	89.35
Total Debt/Total Assets (%)	- -	23.23	24.57	40.21	35.66	42.28	30.86	30.68	31.98	34.41	50.03	53.64	50.83	51.3	46.52
CFO/Total Liabilities	249.4	29.55	30.6	20.71	30.68	20.27	28.75	32.66	31.98	31.28	9.34	16.41	14.26	17.63	18.47
CFO/CapEx	26.23	11.11	17.73	1.71	14.79	3.23	6.08	6.08	4.26	2.37	17.1	2.55	25.42	29.04	6.46
Altman's Z-Score	17.72	4.57	7.6	6.01	6.18	6.77	6.81	5.91	5.44	4.62	2.65	3.28	2.82	2.81	2.55

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	9.65	10.67	8.71	7.54	6.69	6.7	7.06	7.75	6.98	6.28	6.45	6.02	5.65	5.72	5.52
Days Sales Outstanding	37.84	34.21	41.9	48.42	54.56	54.45	51.68	47.1	52.33	58.1	56.61	60.59	64.6	63.8	66.18
Inventory Turnover	3.11	5.15	3.7	4	4.14	3.94	2.85	2.53	1.94	1.71	0.75	0.61	0.66	0.83	1.12
Days Inventory Outstanding	117.22	70.82	98.61	91.25	88.09	92.65	128.02	144.45	187.68	213.24	483.67	603.29	549.33	441.18	325.41
Accounts Payable Turnover	3.13	9.62	5.65	5.15	3.92	5.43	5.1	4.04	3.56	4.56	22.29	1.9	3.29	3.64	4.4
Accounts Payable Turnover Days	116.55	37.96	64.56	70.87	93.16	67.26	71.52	90.34	102.59	80.04	16.38	191.73	110.86	100.16	82.96
Cash Conversion Cycle	38.51	67.08	75.95	68.79	49.49	79.84	108.18	101.21	137.42	191.3	523.9	472.14	503.07	404.83	308.63
Inventory to Cash Days	-79.38	-36.61	-56.72	-42.83	-33.53	-38.2	-76.34	-97.35	-135.36	-155.14	-427.06	-542.7	-484.73	-377.38	-259.23
Inventories	4	27	29	30	19	34	43	53	79	95	1,073	714	597	480	417
Raw Materials	2	5	4	4	3	2	4	11	14	16	22	21	26	20	22
Work In Process	1	5	10	10	12	19	16	21	37	46	887	518	432	312	253
Finished Goods	1	16	15	17	5	14	24	21	28	34	164	176	140	149	142
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	1,603	3,016	7,378	9,782	8,607	6,596	8,081	7,435	8,471	9,195	7,605	9,963	7,785	7,615	10,367
- Cash & Cash Equivalents	82	387	637	684	989	366	386	310	637	1,058	591	881	1,506	2,413	1,392
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	457	550	1,342	1,188	2,030	1,581	1,596	1,771	2,249	6,153	5,812	5,792	6,162	5,424
Enterprise Value	1,445	3,086	7,292	10,441	8,806	8,200	9,061	8,206	9,165	9,312	13,166	14,894	11,950	10,785	13,349
Total Capital	-350	396	569	1,377	1,491	2,559	2,499	2,438	2,839	3,409	6,983	6,546	6,670	7,290	6,070
Total Debt/Capital (%)	- -	115.48	96.73	97.47	79.7	79.33	63.27	65.49	62.39	65.98	88.11	88.79	86.83	84.53	89.35
Total Debt / EV	- -	0.15	0.08	0.13	0.13	0.25	0.17	0.19	0.19	0.24	0.47	0.39	0.48	0.57	0.41
EV/Sales	5.31	5.27	8.36	8.9	6.65	5.51	5.6	4.34	4.24	3.94	4.26	4.07	3.12	2.65	3.13
EV/EBITDA	10.65	11.34	17.06	18.28	13.59	11.25	11.63	9.38	9.05	8.92	18.22	13.04	9.67	7.78	11
EV/EBIT	11.31	15.6	21.12	23.86	16.32	13.32	14.76	12.48	14.27	12.16	77.32	29.07	20	14.84	25.79
EV/Cash Flow to Firm	9.43	11.24	23.73	24.42	15.32	12.84	11.63	9.48	10.65	9.43	8.27	10.36	7.98	6.42	9.1
EV/Free Cash Flow to Firm	9.09	10.39	22.53	15.66	14.41	9.98	10.14	8.23	8.79	6.81	8.04	7.69	7.76	6.24	7.96
Diluted Market Cap	1,808	3,205	7,792	10,252	8,860	6,746	8,256	7,589	8,591	9,328	7,605	9,963	8,864	8,129	10,367
Diluted Enterprise Value	1,726	3,275	7,706	10,910	9,060	8,409	9,451	8,876	9,725	10,520	13,166	14,894	13,149	11,878	14,399
EV per Share	34.83	54.48	125.08	174.75	143.82	135.54	150.98	136.83	161.51	167.14	220.57	238.15	188.81	174.4	218.9
TTM Sales	272	586	872	1,173	1,325	1,488	1,619	1,891	2,162	2,364	3,094	3,659	3,834	4,069	4,268
TTM EBITDA	136	272	427	571	648	729	779	874	1,013	1,044	723	1,142	1,236	1,387	1,214
TTM Operating Income	128	198	345	438	540	615	614	658	642	765	170	512	598	727	518
TTM Cash Flow to Firm	153	275	307	428	575	639	779	866	860	987	1,591	1,438	1,498	1,680	1,466
TTM Free Cash Flow to Firm	159	297	324	667	611	822	893	997	1,043	1,366	1,637	1,936	1,541	1,728	1,676

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	11.49	11.77	25.57	15.86	15.6	8.69	10.23	8.16	8.96	7.29	9.23	5.63	7.81	5.63	6.62
EV/EBIT	11.31	15.6	21.12	23.86	16.32	13.32	14.76	12.48	14.27	12.16	77.32	29.07	20	14.84	25.79
Enterprise Value	1,445	3,086	7,292	10,441	8,806	8,200	9,061	8,206	9,165	9,312	13,166	14,894	11,950	10,785	13,349
Low Price	18.85	37.9	50.76	120.38	117.26	95.8	109.14	113.52	116.52	86.88	117.64	125.36	111.25	99.06	95.49
EV/Sales	5.31	5.27	8.36	8.9	6.65	5.51	5.6	4.34	4.24	3.94	4.26	4.07	3.12	2.65	3.13
EV/EBITDA	10.65	11.34	17.06	18.28	13.59	11.25	11.63	9.38	9.05	8.92	18.22	13.04	9.67	7.78	11
Price/Earnings	12.83	10.45	34.11	167.54	26.12	16.62	16.57	16.63	16.19	38.54	- -	- -	18.77	13.6	- -
Price/Earnings Average	11.06	9.61	20.46	155.85	30.73	19.77	17.63	21.16	14.51	29.95	-28.05	-41.71	20.61	12.69	-21.95
Price/Earnings High	15.9	11.78	34.63	188.12	36.18	24.39	20.15	24.68	16.72	38.76	-34.22	-47.44	24.56	14.81	-31.33
Price/Earnings Low	6.26	7.44	13.68	123.18	21.79	14.61	13.43	15.23	12.63	20.28	-21.3	-34.99	16.97	10.94	-16.35
Price/Book Value	-4.58	-49.26	396.83	281.38	28.43	12.47	8.8	8.84	7.93	7.93	9.16	13.58	8.86	6.75	16.04
Price/Book Value Average	-3.95	-45.29	238.01	261.75	33.45	14.83	9.37	11.25	7.11	6.16	11.14	12.74	9.73	6.3	12.1
Price/Book Value High	-5.68	-55.5	402.88	315.94	39.39	18.3	10.71	13.12	8.2	7.97	13.59	14.49	11.59	7.36	17.27
Price/Book Value Low	-2.24	-35.06	159.16	206.88	23.72	10.96	7.14	8.09	6.19	4.17	8.46	10.69	8.01	5.43	9.01
Price/Tangible Book Value	11.45	-15.77	225.76	-12.72	-35.26	-3.25	-6.66	-8.25	-33.88	18.16	-1.52	-2.26	-2.27	-3.2	-5.34
Price/Tangible Book Value Average	9.88	-14.5	135.4	-11.83	-41.48	-3.87	-7.09	-10.49	-30.36	14.11	-1.84	-2.12	-2.49	-2.99	-4.03
Price/Tangible Book Value High	14.19	-17.77	229.2	-14.28	-48.85	-4.77	-8.1	-12.24	-35.01	18.26	-2.25	-2.42	-2.97	-3.49	-5.75
Price/Tangible Book Value Low	5.59	-11.22	90.55	-9.35	-29.41	-2.86	-5.4	-7.55	-26.45	9.56	-1.4	-1.78	-2.05	-2.58	-3
Price/Sales	5.89	5.15	8.46	8.34	6.5	4.43	4.99	3.93	3.92	3.89	2.46	2.72	2.03	1.87	2.43
Price/Sales Average	5.08	4.73	5.07	7.76	7.64	5.27	5.31	5	3.51	3.02	2.99	2.55	2.23	1.75	1.83
Price/Sales High	7.3	5.8	8.59	9.36	9	6.51	6.07	5.84	4.05	3.91	3.65	2.9	2.66	2.04	2.61
Price/Sales Low	2.87	3.66	3.39	6.13	5.42	3.9	4.05	3.6	3.06	2.05	2.27	2.14	1.84	1.51	1.36
Price/Cash Flow	10.57	12.08	25.58	24	16.18	11.14	11.66	9.31	10.91	10.22	9.77	7.83	7.13	5.46	7.65
Price/Cash Flow Average	9.12	11.11	15.34	22.32	19.04	13.24	12.41	11.84	9.78	7.94	11.88	7.35	7.83	5.09	5.77
Price/Cash Flow High	13.11	13.61	25.97	26.95	22.42	16.34	14.18	13.81	11.27	10.28	14.49	8.36	9.33	5.94	8.23
Price/Cash Flow Low	5.16	8.6	10.26	17.65	13.5	9.78	9.45	8.52	8.52	5.38	9.02	6.16	6.45	4.39	4.3
Price/Free Cash Flow Average	9.91	10.83	15.34	14.75	18.36	10.34	10.89	10.38	8.03	5.67	11.22	5.28	8.58	5.25	4.99
Price/Free Cash Flow High	14.24	13.27	25.96	17.8	21.61	12.76	12.44	12.11	9.26	7.34	13.69	6.01	10.22	6.13	7.13
Price/Free Cash Flow Low	5.61	8.38	10.26	11.66	13.02	7.64	8.29	7.47	6.99	3.84	8.52	4.43	7.06	4.53	3.72
EV/Sales Average	4.78	4.85	4.97	8.32	7.79	6.39	6.05	5.68	4.04	3.53	4.79	3.9	3.35	2.67	2.78
EV/Sales High	7	5.92	8.49	9.93	9.15	7.62	6.81	6.52	4.57	4.42	5.44	4.25	3.77	2.96	3.56
EV/Sales Low	2.57	3.78	3.29	6.69	5.57	5.01	4.78	4.28	3.58	2.55	4.07	3.49	2.95	2.43	2.31
EV/EBITDA Average	9.59	10.45	10.15	17.08	15.94	13.04	12.58	12.29	8.62	7.99	20.49	12.5	10.38	7.83	9.76
EV/EBITDA High	14.04	12.75	17.32	20.38	18.71	15.56	14.15	14.09	9.76	10	23.3	13.63	11.71	8.69	12.51
EV/EBITDA Low	5.16	8.15	6.72	13.74	11.39	10.23	9.94	9.26	7.65	5.78	17.41	11.19	9.16	7.12	8.12
EV/EBIT Average	10.18	14.37	12.57	22.3	19.13	15.45	15.96	16.34	13.58	10.89	86.96	27.87	21.48	14.94	22.89
EV/EBIT High	14.9	17.53	21.44	26.61	22.46	18.43	17.96	18.73	15.39	13.64	98.92	30.38	24.22	16.58	29.35
EV/EBIT Low	5.48	11.2	8.32	17.94	13.67	12.12	12.62	12.31	12.06	7.88	73.9	24.93	18.95	13.59	19.04
Last Price	38.63	53.25	126.56	163.73	140.56	109.03	134.65	123.96	149.28	165.05	127.4	159.31	123	123.15	170
High Price	47.88	60	128.49	183.84	194.73	160	163.75	184	154.24	166	189	169.98	160.96	134.17	182.99
Enterprise Value Average	1,301	2,843	4,339	9,758	10,325	9,507	9,797	10,747	8,725	8,337	14,807	14,276	12,834	10,855	11,850
Enterprise Value High	1,905	3,468	7,404	11,642	12,123	11,344	11,023	12,322	9,887	10,440	16,844	15,561	14,473	12,046	15,191
Enterprise Value Low	700	2,216	2,873	7,851	7,380	7,460	7,745	8,095	7,746	6,032	12,584	12,771	11,326	9,875	9,855

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	42	58	58	61	61	60	60	58	56	56	62	63	62	61	61
Diluted Weighted Avg Shares	47	60	62	63	63	62	61	61	58	57	60	63	72	66	61
Basic Weighted Avg Shares	41	57	58	60	61	60	60	60	57	56	60	63	63	62	61
Revenue per Share	6.56	10.35	14.96	19.63	21.64	24.59	26.97	31.53	38.09	42.42	51.83	58.51	60.58	65.8	69.98
EBITDA per Share	3.27	4.8	7.33	9.56	10.58	12.05	12.98	14.58	17.84	18.73	12.11	18.26	19.53	22.42	19.91
Operating Income per Share	3.08	3.49	5.92	7.32	8.81	10.17	10.23	10.97	11.32	13.74	2.85	8.19	9.44	11.75	8.49
Basic EPS, GAAP	3.01	5.09	3.71	0.98	5.38	6.56	8.13	7.45	9.22	4.28	-5.52	-3.58	6.55	9.06	-5.84
Basic EPS from Cont Ops	3.01	4.61	3.71	0.96	5.38	6.56	8.13	7.45	9.22	4.28	-5.52	-3.58	6.55	9.06	-5.84
Diluted EPS, GAAP	2.67	4.79	3.51	0.93	5.23	6.41	7.96	7.3	9.09	4.22	-5.52	-3.58	5.76	8.49	-5.84
Diluted EPS from Cont Ops	2.67	4.34	3.51	0.92	5.23	6.41	7.96	7.3	9.09	4.22	-5.52	-3.58	5.76	8.49	-5.84
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	3.65	4.41	4.95	6.82	8.69	9.79	11.55	13.32	13.68	16.15	13.04	20.34	17.25	22.57	22.23
Free Cash Flow per Basic Share	3.51	4.01	4.67	2.82	8.1	6.76	9.65	11.13	10.47	9.34	12.28	12.37	16.57	21.8	18.79
Cash & Equivalents per Share	3.8	6.84	10.92	11.45	16.15	7.04	10.01	13.75	18.98	38.28	9.91	14.09	25.7	48.4	40.04
Book Value per Share	-8.43	-1.08	0.32	0.58	4.94	8.74	15.3	14.02	18.82	20.82	13.91	11.73	13.88	18.23	10.6
Tangible Book Value per Share	3.37	-3.38	0.56	-12.87	-3.99	-33.53	-20.22	-15.03	-4.41	9.09	-84.01	-70.38	-54.26	-38.46	-31.82

Jazz Pharmaceuticals plc

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)